Cole Pinnow - 23 Jan 2025 Form 4 Insider Report for Cogent Biosciences, Inc. (COGT)

Role
Chief Commercial Officer
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
Issuer symbol
COGT
Transactions as of
23 Jan 2025
Net transactions value
$0
Form type
4
Filing time
27 Jan 2025, 17:00:07 UTC
Previous filing
15 Jan 2025
Next filing
19 Dec 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COGT Stock Option (Right to Buy) Award $0 +240,000 $0.000000 240,000 23 Jan 2025 Common Stock 240,000 $8.89 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This stock option shall vest in equal monthly installments over a four year period.